FBR Capital Reiterates a 'Market Perform' on BioMed Realty (BMR); Acquisitions Continue to Support FFO Growth
Tweet Send to a Friend
FBR Capital reiterates a 'Market Perform' on BioMed Realty (NYSE: BMR), PT $19.50.
FBR analyst says, "Our investment thesis remains ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
FBR analyst says, "Our investment thesis remains ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
